Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 13 , ISSUE 6 ( November-December, 2021 ) > List of Articles

ORIGINAL RESEARCH

Comparison of Inflammatory Parameters in Coronavirus Disease 2019-infected Pregnant Women and Age-matched Nonpregnant Women

Deepika Naidu, Meena Priyadharshini, Krithika V Senthilkumar, Usha Sekkizhar, Jeevithan Shanmugam

Citation Information : Naidu D, Priyadharshini M, Senthilkumar KV, Sekkizhar U, Shanmugam J. Comparison of Inflammatory Parameters in Coronavirus Disease 2019-infected Pregnant Women and Age-matched Nonpregnant Women. J South Asian Feder Obs Gynae 2021; 13 (6):359-362.

DOI: 10.5005/jp-journals-10006-1982

License: CC BY-NC 4.0

Published Online: 04-03-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Aim: This study aims to compare inflammatory parameters in coronavirus disease-2019 (COVID-19)-infected pregnant women and age-matched nonpregnant women. Materials and methods: It was a cross-sectional study, and data were collected retrospectively. Pregnant women (cases) with COVID infection admitted to the hospital between July 2020 and December 2020 were included in the study. Age-matched nonpregnant women who were also COVID-positive were taken as controls. Their demographic data, comorbidities, and inflammatory markers were compared. The results were compared using descriptive analysis (clinical profile and outcome of patients). Bivariate analysis was done using Chi-square/Fischer exact test; t-test was used to compare the mean biochemical/pathological parameters between the groups. The clinical outcomes (intensive care unit [ICU] admission, O2 requirement, and mortality) were also noted. Results: A total of 228 women (116 pregnant and 112 nonpregnant) were enrolled in the study. The average age of cases was 27 years, while that of controls was 29 years. There was no statistically significant difference in the incidence of comorbidities (anemia, hypertension, diabetes mellitus, asthma, and hypothyroidism) between the two groups. Compared to the controls, pregnant women did not have any significant difference in the levels of D-dimer, lactate dehydrogenase, and serum ferritin, but there were significant differences (p <0.05) in the values of total count neutrophils, lymphocytes, interleukin-6, and international normalized ratio. We did not have any mortality in either group, and only one patient from the study group needed ICU admission. Conclusion: We were able to point out the inflammatory markers that were significantly altered in COVID-positive pregnant women. The markers may help us understand the severity and clinical outcome of the disease better in the future, so that appropriate preventive measures can be taken. Clinical significance: From our study, we were able to identify the markers that were significantly altered due to COVID-19 infection in pregnant women. These markers may play a role in predicting the outcome of the disease and help in deciding an effective treatment plan.


HTML PDF Share
  1. Sohrabi C, Alsafi Z, O'neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020;76:71–76. DOI: 10.1016/j.ijsu.2020.02.034.
  2. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav 2012;62(3):263–271. DOI: 10.1016/j.yhbeh.2012.02.023.
  3. Hassan N, Muzamil M, Banday D. COVID-19 infection during pregnancy–maternal and perinatal outcomes: a tertiary care centre study. Int J Reprod Contracept Obstet Gynecol 2020;9(9):3764. DOI: 10.18203/2320-1770.ijrcog20203853.
  4. Schwartz DA, Graham AL. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020;12(2):194. DOI: 10.3390/v12020194.
  5. Davenport MH, Ruchat SM, Poitras VJ, et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Br J Sports Med 2018;52(21):1367–1375. DOI: 10.1136/bjsports-2018-099355.
  6. Liu D, Li L, Wu X, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol 2020;215(1):127–132. DOI: 10.2214/AJR.20.23072.
  7. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395(10226):809–815. DOI: 10.1016/S0140-6736(20)30360-3 [Erratum in: Lancet 2020;395(10229):1038].
  8. Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab 2020;144(7):799–805. DOI: 10.5858/arpa.2020-0901-SA.
  9. Deng G, Zeng F, Zhang L, et al. Characteristics of pregnant patients with COVID-19 and liver injury. J Hepatol 2020;73(4):989–991. DOI: 10.1016/j.jhep.2020.06.022.
  10. Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis 2020;96:467–474. DOI: 10.1016/j.ijid.2020.05.055.
  11. Tanacan A, Yazihan N, Erol SA, et al. The impact of COVID-19 infection on the cytokine profile of pregnant women: a prospective case-control study. Cytokine 2021;140:155431. DOI: 10.1016/j.cyto.2021.155431.
  12. Sabaka P, Koščálová A, Straka I, et al. Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak. BMC Infect Dis 2021;21(1):308. Available from: https://rdcu.be/cxNwy. DOI: 10.1186/s12879-021-05945-8.
  13. Teli A, Doddamani P, Bagali S. A study of respiratory rate, tidal volume, inspiratory capacity and inspiratory reserve volume in different trimesters of pregnancy. Int J Health Allied Sci 2013;2(4):294–297. DOI: 10.4103/2278-344X.126766.
  14. Dennis AT, Hardy L. Defining a reference range for vital signs in healthy term pregnant women undergoing cesarean section. Anaesth Intensive Care 2016;44(6):752–757. DOI: 10.1177/0310057X1604400619.
  15. Blitz MJ, Grünebaum A, Tekbali A, et al. Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease 2019. Am J Obstet Gynecol 2020;223(2):290–291. DOI: 10.1016/j.ajog.2020.05.004.
  16. Agarwal N, Garg R, Singh S, et al. Coronavirus disease 2019 in pregnancy: maternal and perinatal outcome. J Educ Health Promot 2021;10(1):194. DOI: 10.4103/jehp.jehp_954_20.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.